THORP CLAY purchased 43.6% of their position (10K shares) of PHASEBIO PHARMACEUTICALS INC on the open market
Open‑market purchase worth $30.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/18/2021ACC: 0001169245-21-000080
Director10% Owner
Since Oct 2018
+10K
Net shares
Net buyer
$30.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$3.00
Trade value
$30K
% of position
43.6%
8/18/2021
22.94K→32.94K
Total
Net shares
+10K
Net value
$30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2021 | P · Purchase | +10K | $3.00 | $30K | 43.6% | 22.94K | 32.94K |
| Total | +10K | $30K | ||||||
Derivative Transactions0
No derivative transactions reported